David Fitzgerald

7.3k total citations · 1 hit paper
120 papers, 6.1k citations indexed

About

David Fitzgerald is a scholar working on Immunology, Biotechnology and Molecular Biology. According to data from OpenAlex, David Fitzgerald has authored 120 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Immunology, 62 papers in Biotechnology and 33 papers in Molecular Biology. Recurrent topics in David Fitzgerald's work include Toxin Mechanisms and Immunotoxins (94 papers), Transgenic Plants and Applications (57 papers) and Monoclonal and Polyclonal Antibodies Research (29 papers). David Fitzgerald is often cited by papers focused on Toxin Mechanisms and Immunotoxins (94 papers), Transgenic Plants and Applications (57 papers) and Monoclonal and Polyclonal Antibodies Research (29 papers). David Fitzgerald collaborates with scholars based in United States, United Kingdom and India. David Fitzgerald's co-authors include Ira Pastan, Vijay K. Chaudhary, Robert J. Kreitman, Antonella Antignani, Sankar Adhya, M Ogata, Mark C. Willingham, Jaulang Hwang, Charlotte M. Fryling and Dudley K. Strickland and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

David Fitzgerald

118 papers receiving 5.9k citations

Hit Papers

Managing the TME to improve the efficacy of cancer therapy 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Managing the TME to improve the efficacy of cancer therapy
    2022 172 citations Maria Teresa Bilotta, Antonella Antignani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Fitzgerald United States 42 3.9k 2.4k 2.2k 1.3k 771 120 6.1k
Arthur E. Frankel United States 40 2.5k 0.7× 2.6k 1.1× 1.3k 0.6× 509 0.4× 1.4k 1.8× 144 5.2k
J. Ignacio Casal Spain 52 1.2k 0.3× 3.9k 1.6× 684 0.3× 570 0.4× 1.4k 1.8× 167 7.4k
David W. Scott United States 49 4.2k 1.1× 2.8k 1.2× 213 0.1× 1.4k 1.1× 1.5k 2.0× 287 8.0k
Naoko Arai Japan 53 6.0k 1.6× 5.3k 2.2× 321 0.1× 829 0.6× 2.2k 2.8× 125 12.3k
Jacques Baenziger United States 55 2.2k 0.6× 7.0k 2.9× 627 0.3× 1.3k 1.0× 444 0.6× 123 9.4k
E S Vitetta United States 43 4.1k 1.1× 1.5k 0.6× 690 0.3× 1.6k 1.2× 852 1.1× 122 5.6k
Yoshio Okada Japan 33 987 0.3× 2.6k 1.1× 590 0.3× 277 0.2× 413 0.5× 212 4.4k
C Gorman United States 20 2.1k 0.5× 6.8k 2.9× 414 0.2× 1.5k 1.1× 2.2k 2.9× 23 11.5k
David L. Urdal United States 38 4.8k 1.2× 2.7k 1.1× 258 0.1× 1.0k 0.8× 1.5k 2.0× 57 7.9k
Mouldy Sioud Norway 42 2.4k 0.6× 4.5k 1.9× 156 0.1× 908 0.7× 856 1.1× 205 6.9k

Countries citing papers authored by David Fitzgerald

Since Specialization
Citations

This map shows the geographic impact of David Fitzgerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fitzgerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fitzgerald more than expected).

Fields of papers citing papers by David Fitzgerald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Fitzgerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fitzgerald. The network helps show where David Fitzgerald may publish in the future.

Co-authorship network of co-authors of David Fitzgerald

This figure shows the co-authorship network connecting the top 25 collaborators of David Fitzgerald. A scholar is included among the top collaborators of David Fitzgerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Fitzgerald. David Fitzgerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Antignani, Antonella, Maria Teresa Bilotta, Jacob S. Roth, et al.. (2023). Birinapant selectively enhances immunotoxin‐mediated killing of cancer cells conditional on the IAP protein levels within target cells. The FASEB Journal. 37(12). e23292–e23292.
2.
Kong, Minsuk, Domenico D’Atri, Maria Teresa Bilotta, et al.. (2023). Cell-specific cargo delivery using synthetic bacterial spores. Cell Reports. 42(1). 111955–111955. 5 indexed citations
3.
Shashaty, M.G.S., John P. Reilly, Hilary Faust, et al.. (2019). Plasma receptor interacting protein kinase-3 levels are associated with acute respiratory distress syndrome in sepsis and trauma: a cohort study. Critical Care. 23(1). 235–235. 34 indexed citations
4.
Palakshappa, Jessica A., John P. Reilly, William D. Schweickert, et al.. (2018). Quantitative peripheral muscle ultrasound in sepsis: Muscle area superior to thickness. Journal of Critical Care. 47. 324–330. 64 indexed citations
5.
Guha, Rajarshi, Lesley A. Mathews Griner, Jonathan M. Keller, et al.. (2016). Ranking Differential Drug Activities from Dose-Response Synthetic Lethality Screens. SLAS DISCOVERY. 21(9). 942–955. 4 indexed citations
6.
Antignani, Antonella, et al.. (2014). ABT-737 Promotes the Dislocation of ER Luminal Proteins to the Cytosol, Including Pseudomonas Exotoxin. Molecular Cancer Therapeutics. 13(6). 1655–1663. 16 indexed citations
7.
Liu, Xiu Fen, David Fitzgerald, & Ira Pastan. (2013). The Insulin Receptor Negatively Regulates the Action of Pseudomonas Toxin-Based Immunotoxins and Native Pseudomonas Toxin. Cancer Research. 73(7). 2281–2288. 16 indexed citations
8.
Kreitman, Robert J., Evgeny Arons, Maryalice Stetler‐Stevenson, et al.. (2011). Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia. Leukemia & lymphoma. 52(sup2). 82–86. 17 indexed citations
9.
Du, Xing, Richard Beers, David Fitzgerald, & Ira Pastan. (2008). Differential Cellular Internalization of Anti-CD19 and -CD22 Immunotoxins Results in Different Cytotoxic Activity. Cancer Research. 68(15). 6300–6305. 105 indexed citations
10.
Alderson, Ralph, Enrique Escandón, Tianling Chen, et al.. (2006). Characterization of CAT-8015: A Pseudomonas exotoxin based immunotoxin for the treatment of CD22-related hematological malignancies. Cancer Research. 66. 877–877. 13 indexed citations
11.
Onda, Masanori, Satoshi Nagata, David Fitzgerald, et al.. (2006). Characterization of the B Cell Epitopes Associated with a Truncated Form of Pseudomonas Exotoxin (PE38) Used to Make Immunotoxins for the Treatment of Cancer Patients. The Journal of Immunology. 177(12). 8822–8834. 92 indexed citations
12.
13.
Daugherty, Ann L., Marian L. McKee, David Fitzgerald, & Randall J. Mrsny. (2000). Epithelial application of Pseudomonas aeruginosa exotoxin A results in a selective targeting to cells in the liver, spleen and lymph node. Journal of Controlled Release. 65(1-2). 297–302. 11 indexed citations
14.
Kreitman, Robert J., Qingcheng Wang, David Fitzgerald, & Ira Pastan. (1999). Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys. International Journal of Cancer. 81(1). 148–155. 78 indexed citations
15.
Ko, Kerry W.S., Roger S. McLeod, Rita Kohen Avramoglu, et al.. (1998). Mutation at the Processing Site of Chicken Low Density Lipoprotein Receptor-related Protein Impairs Efficient Endoplasmic Reticulum Exit, but Proteolytic Cleavage Is Not Essential for Its Endocytic Functions. Journal of Biological Chemistry. 273(43). 27779–27785. 22 indexed citations
16.
17.
Kreitman, R. J., Vijay Chaudhary, Clay B. Siegall, David Fitzgerald, & Ira Pastan. (1992). Rational design of a chimeric toxin: an intramolecular location for the insertion of transforming growth factor .alpha. within Pseudomonas exotoxin as a targeting ligand. Bioconjugate Chemistry. 3(1). 58–62. 19 indexed citations
18.
Béraud, Evelyne, Haya Lorberboum‐Galski, Chi Chao Chan, et al.. (1991). Immunospecific suppression of encephalitogenic-activated T lymphocytes by chimeric cytotoxin IL-2-PE40. Cellular Immunology. 133(2). 379–389. 13 indexed citations
19.
Heimbrook, David, Steven M. Stirdivant, Denis R. Patrick, et al.. (1991). Biological activity of a transforming growth factor-alpha-Pseudomonas exotoxin fusion protein in vitro and in vivo. Journal of Industrial Microbiology & Biotechnology. 7(3). 203–207. 2 indexed citations
20.
Prior, Trevor I., David Fitzgerald, & Ira Pastan. (1991). Barnase toxin: A new chimeric toxin composed of pseudomonas exotoxin A and barnase. Cell. 64(5). 1017–1023. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arthur E. Frankel Breakdown of academic impact, for papers by J. Ignacio Casal Breakdown of academic impact, for papers by David W. Scott Breakdown of academic impact, for papers by Naoko Arai Breakdown of academic impact, for papers by Jacques Baenziger Breakdown of academic impact, for papers by E S Vitetta Breakdown of academic impact, for papers by Yoshio Okada Breakdown of academic impact, for papers by C Gorman Breakdown of academic impact, for papers by David L. Urdal Breakdown of academic impact, for papers by Mouldy Sioud
Rankless by CCL
2026